Chondrosarcomas Recruiting Phase 2 Trials for Regorafenib (DB08896)

Also known as: Chondrosarcoma / Chondroma sarcomatosum / Chondrosarcoma NOS / [M]Chondrosarcoma NOS

IndicationStatusPhase
DBCOND0036125 (Chondrosarcomas)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02389244A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone SarcomasTreatment